MHRA’s AI Airlock to address challenges for regulating AI medical devices
The sandbox will help to inform future AI Airlock projects and influence future AlaMD guidance
Read More
Tag: AI Airlock
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
